The House Ways and Means Committee has cleared a proposed amendment to the Physician Payment Sunshine Act that would require manufacturers and suppliers to report to the CMS the value of any samples of medical devices, drugs and biologicals they give to physicians. This could include samples used for educational purposes.
House panel OKs Physician Payment Sunshine Act amendment
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.